Akero
0 followers
Akero Therapeutics is a clinical-stage cardio-metabolic company developing transformational treatments for non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Akero's lead product candidate, efruxifermin (EFX), an engineered Fc-FGF21 fusion protein, is currently being eva... Read more
Org chart
Andrew Cheng
President & CEO
Andrew Cheng
Collapse
Jonathan Young
COO & Co Founder
Tim Rolph
Chief Scientific Officer & Co-Founder
William White
CFO & Head of Corporate Development
Catriona Yale
Chief Development Officer
Dominick Villani
VP & Quality
Brittany de Temple
VP of Development Operations
Libette Luce
VP of Regulatory Affairs
Patrick Lamy
SVP, Commercial Strategy
Kitty Yale
EVP And Chief Development Officer
David West
Vice President Legal
Similar companies
Kula Bio
1 follower
Odyssey Therapeutics
2 followers
Gilead Sciences
119 followers
Regeneron
87 followers
Pearson
58 followers
Exact Sciences
15 followers
10X Genomics
11 followers
Tulane University
11 followers
Portland Public Schools
11 followers
Foundation Medicine
5 followers
Vera Therapeutics
2 followers
Discover companies